Discontinuation report RAPAFLO
| Report ID | 149531 |
| Drug Identification Number | 02361671 |
| Brand name | RAPAFLO |
| Common or Proper name | Silodosin Capsules |
| Company Name | ALLERGAN INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | SILODOSIN |
| Strength(s) | 8MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | HDPE Bottle 90s |
| ATC code | G04CA |
| ATC description | DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2021-11-17 |
| Actual discontinuation date | 2022-10-31 |
| Remaining supply date | 2022-10-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v11 | 2022-11-14 | French | Compare |
| v10 | 2022-11-14 | English | Compare |
| v9 | 2022-11-14 | French | Compare |
| v8 | 2022-11-14 | English | Compare |
| v7 | 2022-11-08 | French | Compare |
| v6 | 2022-11-08 | English | Compare |
| v5 | 2022-11-08 | English | Compare |
| v4 | 2022-03-15 | French | Compare |
| v3 | 2022-03-15 | English | Compare |
| v2 | 2021-11-18 | French | Compare |
| v1 | 2021-11-17 | English | Compare |
Showing 1 to 11 of 11